Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Umea University
Sponsor

Umea University

Sweden Universitetstorget 4, Alidhem, 907 36 Umea, Sweden

About the sponsor

Clinical research in prostate cancer focuses on advanced imaging, lesion detection, and treatment strategies for metastatic hormone-sensitive disease and PSMA-positive tumours.

  • PSMA-PET
  • mpMRI
  • Radiographic progression-free survival
  • Histopathologic validation

The sponsor also supports work on identifying clinically relevant intra-prostatic sub-regions and refining imaging-based assessment in high-risk disease.

About Specializations

Umea University runs clinical trials in conditions such as Prostate cancer, Vestibular disorder, Dengue fever, General anaesthesia, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

7 clinical trials

Vestibular disorder

Recruiting

A Study of Prednisolone Compared to Placebo for Patients with Vestibular Neuritis to Evaluate Effects on Balance and Dizziness Symptoms

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Prednisolone
  • Sponsor:Region Vaesterbotten

Dengue fever

Recruiting

Study on the Effects of the Dengue Vaccine Qdenga on Antibody Levels in Swedish Travelers

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:DENGUE VIRUS, SEROTYPE 2, EXPRESSING DENGUE VIRUS, SEROTYPE 1, SURFACE PROTEINS, LIVE, ATTENUATED
  • Sponsor:Region Vaesterbotten

General anaesthesia

Recruiting

Study on Low Oxygen and Nitrous Oxide Use During Anesthesia for Surgery Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nitrous Oxide
  • Sponsor:Region Vaesterbotten

Prostate cancer

Recruiting

Study on the Use of 18F-PSMA-1007, Hyoscine Butylbromide, and Gadoteric Acid in Imaging for Patients with High-Risk Prostate Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Gadoteric Acid
  • Sponsor:Region Vaesterbotten

Prostate cancer

Recruiting

Study Comparing 177Lu-PSMA-I&T with Apalutamide, Enzalutamide, and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:Region Vaesterbotten

COVID-19

Not yet recruiting

Study of Intravenous Immunoglobulin Added to Standard Treatment for COVID-19 in Patients with Severely Weakened Immune System Due to B-cell Problems

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nirmatrelvir
  • Sponsor:Region Vaesterbotten

Prophylaxis of nausea and vomiting

Not yet recruiting

Study of palonosetron and fosaprepitant to prevent nausea and vomiting after laparoscopic surgery

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Fosaprepitant
  • Sponsor:Region Vaesternorrland

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.